Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
filingDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107903323-B |
titleOfInvention |
anti-hTNF- α fully human antibody and application thereof |
abstract |
The invention relates to an anti-hTNF- α fully human antibody and an application thereof, wherein the antibody consists of a heavy chain and a light chain, the amino acid sequence of the heavy chain is shown as SEQ ID No.1, the amino acid sequence of the light chain is shown as SEQ ID No.2, the amino acid sequence of a variable region of the heavy chain is shown as SEQ ID No.3, and the amino acid sequence of a variable region of the light chain is shown as SEQ ID No. 4. |
priorityDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |